BIOPLUS-INTERPHEX KOREA 2026 closed at COEX on Friday with its shortest conference day and, in some ways, its most forwa...
Regenerative medicine is entering a defining phase as stem-cell research moves beyond laboratory discoveries towards cli...
American multinational pharmaceutical company Merck (Known as Merck Sharp & Dohme or MSD outside the United States a...
If Day 1 of BIX 2026 asked what makes a Korean asset partnerable, Day 2 asked what happens once someone wants it. Thursd...
Ask most investors to name South Korea's bio clusters and the list starts with Songdo, moves on to Pangyo and Osong, and...
Brain–computer interfaces (BCIs) are entering a new phase of technological development, moving beyond experimental...
Japan-based Astellas Pharma Inc. has entered into an exclusive option and license agreement for DAX-044, Audax’s l...
PeptiDream Inc., a public biopharmaceutical company based in Kawasaki, Japan, focused on the discovery and development o...
CELSET INC., a Korean biotechnology company specialising in medical aesthetics, has launched SOLTOX, its botulinum toxin...
Japan-based Otsuka Pharmaceutical has announced that Otsuka BioVentures, LLC (OBV), a corporate venture capital (CVC) fi...
US-based Gilead Sciences, Inc. has entered into a definitive agreement to acquire an oral IL-23R inhibitor programme, in...
MedTech Innovator (MTI), the world’s largest accelerator of medical device, digital health, and diagnostic compani...
United Imaging Healthcare's uMR Jupiter 5T MRI system has been officially introduced at Hanoi Medical University Hospita...
US-based Natus Medical Incorporated, the world's largest pure-play neurodiagnostic company, recently celebrated the gran...
US-based Labcorp, a global leader of innovative and comprehensive laboratory services, and Waters Corporation, a global ...
Kaigene, Inc., a US-based biotechnology company developing antibody medicines for autoimmune diseases, has announced an ...
AI Proteins, Inc., a US-based biotechnology company that utilises computational de novo protein design to create therape...
Taiwan-based HanchorBio, Inc., a global clinical-stage biotechnology company, and Aston Sci, Inc., a South Korea-based c...
Galderma has announced that the Chinese National Medical Products Administration (NMPA) has approved Relf...
Revenue Grew 9% Including 6% Organic Revenue Growth Grew GAAP Diluted EPS 9% and Adjusted EPS 15% Outstanding perfor...
ESTEVE CDMO, Esteve Healthcare contract development and manufacturing organization, is strengthening its presence in Asi...
NovAccel, Inc., a Japanese deep-tech company developing proprietary superconducting accelerator technology for medical r...
South Korea-based Samsung Bioepis has announced a landmark 10-year agreement with its local partners in Brazil—sta...
Healthcare is generating more data than ever, yet much of its potential remains locked within disconnected systems. As a...
Asia-Pacific stands at a defining moment in interventional cardiology, where technological advancement must be m...
